Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial

医学 乳腺癌 随机对照试验 癌症 内科学 家庭医学
作者
Lena Saltbæk,Pernille Envold Bidstrup,Randi V. Karlsen,Beverley Lim Høeg,Trine Allerslev Horsbøl,Federica Belmonte,Elisabeth Wreford Andersen,Vibeke Zoffmann,Anne Sofie Friberg,Mads Nordahl Svendsen,Helle Gert Christensen,Vesna Glavicic,Dorte Lisbet Nielsen,Susanne Oksbjerg Dalton,Christoffer Johansen
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:42 (17): 2038-2049 被引量:35
标识
DOI:10.1200/jco.23.01447
摘要

PURPOSE Follow-up after breast cancer with regular visits has failed to detect recurrences, be cost-effective, and address patient needs. METHODS MyHealth is a phase III randomized controlled trial (ClinicalTrials.gov identifier: NCT02949167 ). Patients, who recently completed primary treatment for stage I-II breast cancer, were randomly assigned in variable block sizes and stratified by age and human epidermal growth factor receptor 2 status to intervention or control follow-up. The nurse-led intervention comprised three to five individual self-management sessions, regular reporting of symptoms, and navigation to health care services. The control follow-up comprised regular outpatient visits with the physician. The primary outcome was breast cancer–specific quality of life (QoL) measured by the Trial Outcome Index-Physical/Functional/Breast summary score of the Functional Assessment of Cancer Therapy-Breast 2 years after random assignment. Secondary outcomes were fear of recurrence, anxiety, depression, and health care utilization. Analyses were intention-to-treat and P values were two-sided with 95% confidence level set at 0.005 because of multiple comparisons. RESULTS Among 1,101 eligible patients, 875 were invited and 503 were randomly assigned to control (n = 252) or intervention (n = 251) follow-up. At 2 years, patients in the intervention group reported a significantly and clinically relevant higher QoL (mean, 75.69 [standard deviation [SD], 12.27]) than patients in the control group (71.26 [SD, 14.08]), with a mean difference of 5.05 (95% CI, 3.30 to 6.79; P < .001). The intervention group reported significantly less fear of recurrence, anxiety, and depression; they had fewer physician consultations but more nurse contacts and an unchanged diagnostic imaging pattern. The effect on all outcomes was stable through a 3-year follow-up. CONCLUSION The MyHealth study suggested a new strategy for follow-up after early breast cancer as it provided significant improvements in QoL.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sunny完成签到 ,获得积分10
1秒前
1秒前
lu7完成签到 ,获得积分10
2秒前
星野的应助被予诺采纳,获得10
3秒前
回锅肉完成签到 ,获得积分10
5秒前
胖球球完成签到,获得积分10
5秒前
Hsy驳回了Lucas的应助
5秒前
好名发布了新的文献求助10
6秒前
ZY发布了新的文献求助10
7秒前
8秒前
11秒前
张颖涛完成签到,获得积分10
11秒前
领导范儿的应助被灭建国采纳,获得10
11秒前
12秒前
隐形曼青的应助被FUTURE采纳,获得30
13秒前
orixero的应助被Joy采纳,获得10
13秒前
Jingxue_ZX的应助被武宁采纳,获得10
16秒前
16秒前
我是谁的应助被朴实归尘采纳,获得50
17秒前
桐桐的应助被孟宇采纳,获得10
17秒前
柚子完成签到,获得积分10
17秒前
领导范儿的应助被大将军采纳,获得10
18秒前
哈哈哈哈发布了新的文献求助10
19秒前
20秒前
20秒前
21秒前
weiqiliang完成签到,获得积分10
21秒前
jason完成签到,获得积分0
21秒前
栖梧砚客完成签到,获得积分10
23秒前
24秒前
折瑾完成签到,获得积分10
26秒前
科研通AI65的应助被开心德地采纳,获得10
26秒前
27秒前
科研通AI65的应助被瘦瘦大米采纳,获得10
27秒前
30秒前
30秒前
31秒前
修炼成绝完成签到,获得积分10
32秒前
34秒前
夏鱼发布了新的文献求助10
35秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188371
求助须知:如何正确求助?哪些是违规求助? 9576179
关于积分的说明 21845965
捐赠科研通 7786421
什么是DOI,文献DOI怎么找? 3435292
关于科研通互助平台的介绍 2559601
邀请新用户注册赠送积分活动 2482276